4.6 Review

Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy

Journal

MOLECULAR NEUROBIOLOGY
Volume 52, Issue 3, Pages 1477-1493

Publisher

SPRINGER
DOI: 10.1007/s12035-014-8958-4

Keywords

Brain-derived neurotrophic factor; Alzheimer's disease; Risk; Pathogenesis; Polymorphism; Therapy

Categories

Funding

  1. National Natural Science Foundation of China [81471309, 81171209, 81371406]
  2. Shandong Provincial Natural Science Foundation, China [ZR2010HQ004, ZR2011HZ001]

Ask authors/readers for more resources

Brain-derived neurotrophic factor (BDNF) has a neurotrophic support on neuron of central nervous system (CNS) and is a key molecule in the maintenance of synaptic plasticity and memory storage in hippocampus. However, changes of BDNF level and expression have been reported in the CNS as well as blood of Alzheimer's disease (AD) patients in the last decade, which indicates a potential role of BDNF in the pathogenesis of AD. Therefore, this review aims to summarize the latest progress in the field of BDNF and its biological roles in AD pathogenesis. We will discuss the interaction between BDNF and amyloid beta (A beta) peptide, the effect of BDNF on synaptic repair in AD, and the association between BDNF polymorphism and AD risk. The most important is, enlightening the detailed biological ability and complicated mechanisms of action of BDNF in the context of AD would provide a future BDNF-related remedy for AD, such as increment in the production or release of endogenous BDNF by some drugs or BDNF mimics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available